Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Corneal vesicles accumulate collagen VI associated with tissue remodeling in apolipoprotein a-I deficiency: a case report

BMC OphthalmologyBMC series – open, inclusive and trusted201717:11

DOI: 10.1186/s12886-017-0404-8

Received: 28 September 2016

Accepted: 23 January 2017

Published: 8 February 2017

Abstract

Background

Apo A-I deficiency clinically shows low serum levels of HDL cholesterol and corneal opacity at a young age. Histopathological evaluations of affected corneas are not enough, and the mechanism of corneal opacity is still unclear.

Case presentation

A 61-year-old woman suffered from blurred vision with a corneal opacity. She had significantly reduced serum levels of high-density lipoprotein cholesterol and Apo A-I, stenosis of the coronary arteries, and ischemic heart failure. On genetic examination, a homozygous mutation of Apo A-ITsukuba was identified. Histopathological examination of the corneal button after PKP showed numerous vesicles in the corneal stroma, which were more prominent in the deep stroma than in the shallow stroma. Collagen VI was observed in some of those vesicles.

Conclusion

We experienced a rare case of corneal opacity due to Apo A-I deficiency. Our histopathological findings indicated that structural changes in corneal collagen fibrils contribute to the formation of stromal vesicles.

Keywords

Case report Apolipoprotein a-I deficiency Collagen VI Confocal microscopy Corneal opacity Immunohistochemistry

Background

Apo A-I is an essential component of HDL. Its deficiency is clinically detected by low serum levels of HDL cholesterol. Although different gene mutations of Apo A-I are reported [14], the typical clinical presentation includes corneal opacity, xanthoma, and ischemic heart disease at a young age. Histopathological evaluations of affected corneas are not enough, and the mechanism of corneal opacity is still unknown. In the present study, we report a part of the mechanism associated with corneal opacity in a case of genetic Apo A-I deficiency.

Case presentation

In 2012, a 61-year-old woman with blurred vision presented with corneal opacity of the left eye. Her visual acuity was 20/40 OS and 20/20 OD. She had been diagnosed with HDL deficiency at the age of 46 years, 1997. but she had been off treatment for about 10 years. She had undergone PKP of the right eye for the same symptoms when she was 58 years old, 2009.

The patient was the fourth of 8 siblings. A brother died in an accident and a sister died in childhood. None of her family members had been diagnosed with HDL deficiency, and there was no family history of consanguineous marriage. On physical examination, she had bilateral xanthomas of the eyelids and focal yellow skin discolorations in the cubital fossae of both forearms, but there was no tonsillar hypertrophy or Achilles tendon xanthoma.

Blood tests showed an extremely low HDL-cholesterol level (6 mg/dL) with undetectable Apo A-I (<5 mg/dL). Levels of Apo B and Apo E were slightly elevated (109 mg/dL and 5.8 mg/dL, respectively). Serum triglyceride, total cholesterol, low-density lipoprotein cholesterol, and lecithin-cholesterol acyltransferase levels were within the normal limits. A genetic evaluation was performed as previously described [4], and showed that she was homozygous for the Apo A-ITsukuba mutation, which is a single-nucleotide insertion of cytosine that alters the reading frame from codon 5 and produces a premature stop codon at codon 34 (Fig. 1). Thus, this patient was diagnosed with genetic Apo A-I deficiency. Electrocardiogram, echocardiogram, and myocardial scintigraphy showed significant ischemic heart failure and angiography showed severe stenosis of the coronary arteries. Consequently, she underwent percutaneous coronary intervention and coronary artery bypass grafting.
Fig. 1

The result of genetic evaluation. A single-nucleotide insertion of cytosine altered the reading frame from codon 5 and produces a premature stop codon at codon 34

On slit-lamp examination, there was a diffuse corneal stromal opacity with a lucid zone in the left eye. Confocal microscopy (Heidelberg Retinal Tomograph Rostock Cornea Module, Heidelberg Engineering, Heidelberg, Germany) revealed high-intensity vesicles (10–100 μm in diameter) in the corneal stroma (Fig. 2). In 2013, PKP was performed for the left eye, and the corneal button tissues were examined histopathologically and immunohistochemically.
Fig. 2

Confocal microscopy in the corneal stroma. High-intensity vesicles, 10 to 100 μm in diameter, were observed

Histopathological and immunohistochemical analysis of the corneal button

The cornea showed normal thickness and there was no significant abnormality of the epithelium, Bowman’s layer, or the endothelium. There were numerous small vesicles in the corneal stroma (Fig. 3a), which were of similar size to the vesicles observed with confocal microscopy. The vesicles were more prominent in the deep stroma than in the shallow stroma. Accumulations in the vesicles were Congo-red negative and alcian-blue positive (Fig. 3b). Sudan III and Sudan black staining could not confirm the presence of cholesterol ester in the vesicles. On immunohistochemical analysis, collagen VI [clone: anti-hCL (VI), mouse IgG1,κ; 1:500; KYOWA PHARMA CHEMICAL CO., LTD., Toyama, Japan] was observed in some vesicles (Fig. 3c).
Fig. 3

Histopathology and immunohistochemistry of the surgically excised corneal button. a Histopathology of the central cornea. There were many small vesicles (10 to 100 μm in diameter) the corneal stroma. The vesicles were much more numerous in the deep stroma than in the upper stroma (hematoxylin and eosin staining; magnification × 40). b Histopathology of the central cornea. Accumulations in the vesicles were alcian-blue positive (alcian-blue staining; magnification × 40). c Collagen VI immunostaining of the central cornea detected collagen VI in some of the vesicles (magnification × 40)

Since the PKP, the patient has been on regular medication with pitavastatin and tocopherol nicotinate and has had a normal lipid profile except for low serum HDL-cholesterol levels. In 2015, her current visual acuity is 20/25 OS and 20/20 OD and both corneal grafts have maintained good transparency.

Discussion

Our patient demonstrated clinical findings typical to Apo A-I deficiency. Histopathologically, vesicles in the corneal stroma were significantly larger (10–100 μm in diameter) than those described in the report by Osakabe and colleagues (200 nm–2 μm in diameter) [5]. Apo A-I mutations, including Apo A-IIowa, are known to induce amyloidosis [6]. However, our patient did not have any accumulation of amyloid in the corneal stroma. It is possible that we failed to detect cholesterol ester in the vesicles by Sudan black staining because we embedded the corneal button in paraffin. It was also regretful that the right cornea had not been examined immunohistochemically.

Collagen VI is a major extracellular matrix protein, bridging cells to the surrounding connective tissue and organizing the three-dimensional tissue architecture. The mutations in the genes encoding Collagen VI chains result in several forms of inherited myopathies, decrease of stiffness in cartilage [7]. It is also distributed in corneal stroma, and reported the change of its expression level during wound healing period [810].

Conclusions

To our knowledge, ours is the first report of a patient with confirmed mucoid degeneration and accumulations of collagen VI in the stromal vesicles. Our results suggest that structural changes in corneal collagen fibrils contribute to the formation of stromal vesicles.

Abbreviations

Apo: 

Apolipoprotein

HDL: 

High-density lipoprotein

OD: 

Oculus Dexter

OS: 

Oculus Sinister

PKP: 

Penetrating keratoplasty

Declarations

Acknowledgements

We thank Editage Author Services for editing this manuscript. We adhered to the CARE guidelines/methodology.

Funding

The case report has no funding involved.

Availability of data and material

The datasets during and/or analysed during the current study available from the corresponding author on reasonable request.

Authors′ contributions

HN and MN drafted the manuscript, collected the data, and participated in the design of the study. SS and RO collected the data including genetic and histopathological evaluation. TK, MY, and HY participated in the design and critically reviewed the manuscript. All authors approved the final manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Ethics approval and consent to participate

Informed consent was obtained from the participant and study conduct adhered to the tenets of the Declaration of Helsinki. The study was approved by the Ethics Committee of the Yamagata University Faculty of Medicine, Yamagata, Japan.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Ophthalmology and Visual Sciences, Yamagata University Faculty of Medicine
(2)
Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine
(3)
Department of Diagnostic Pathology, Yamagata University Faculty of Medicine

References

  1. Schaefer EJ, Ordovas JM, Law SW, Ghiselli G, Kashyap ML, Srivastava LS, Heaton WH, Albers JJ, Connor WE, Lindgren FT, et al. Familial apolipoprotein a-I and C-III deficiency, variant II. J Lipid Res. 1985;26:1089–101.PubMedGoogle Scholar
  2. Ikewaki K, Matsunaga A, Han H, Watanabe H, Endo A, Tohyama J, Kuno M, Mogi J, Sugimoto K, Tada N, Sasaki J, Mochizuki S. A novel two nucleotide deletion in the apolipoprotein a-I gene, apoA-I shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease. Atherosclerosis. 2004;172:39–45.View ArticlePubMedGoogle Scholar
  3. Bandarian F, Hedayati M, Daneshpour MS, Naseri M, Azizi F. Genetic polymorphisms in the APOA1 gene and their relationship with serum HDL cholesterol levels. Lipids. 2013;48:1207–16.View ArticlePubMedGoogle Scholar
  4. Wada M, Iso T, Asztalos BF, Takama N, Nakajima T, Seta Y, Kaneko K, Taniguchi Y, Kobayashi H, Nakajima K, Schaefer EJ, Kurabayashi M. Marked high density lipoprotein deficiency due to apolipoprotein a-I tomioka (codon 138 deletion). Atherosclerosis. 2009;207:157–61.View ArticlePubMedGoogle Scholar
  5. Osakabe Y, Amano S, Fukuoka S, Yamagami S. Histologic evaluation of a cornea in a patient with apolipoprotein a-I deficiency. Cornea. 2008;27:372–3.View ArticlePubMedGoogle Scholar
  6. Nakata K, Kobayashi K, Yanagi H, Shimakura Y, Tsuchiya S, Arinami T, Hamaguchi H. Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein a-I gene. Biochem Biophys Res Commun. 1993;129:950–5.View ArticleGoogle Scholar
  7. Cescon M, Gattazzo F, Chen P, Bonaldo P. Collagen VI at a glance. J Cell Sci. 2015;128:3525–31.View ArticlePubMedGoogle Scholar
  8. El-Shabrawi Y, Kublin CL, Cintron C. MRNA levels of alpha1(VI) collagen, alpha1(XII) collagen, and beta ig in rabbit cornea during normal development and healing. Invest Ophthalmol Vis Sci. 1998;39:36–44.PubMedGoogle Scholar
  9. Koch DD. Histological changes and wound healing response following noncontact holmium: YAG laser thermal keratoplasty. Trans Am Ophthalmol Soc. 1996;94:745–802.PubMedPubMed CentralGoogle Scholar
  10. Cintron C, Hong BS. Heterogeneity of collagens in rabbit cornea: type VI collagen. Invest Ophthalmol Vis Sci. 1988;29:760–6.PubMedGoogle Scholar

Copyright

© The Author(s). 2017